17 November 2019
Melbourne Sexual Health Continue Success with Resistance Guided Therapy
Mycoplasma genitalium (Mgen) infections treated using resistance guided therapy led to high cure rates and low levels of de novo...
8 November 2019
FIND Collaborate with SpeeDx and QuantuMDx
The Foundation for Innovative New Diagnostics (FIND) are supporting a collaboration with SpeeDx and QuantuMDx to assess the feasibility of...
29 October 2019
TGA Clears ResistancePlus® MG FleXible for Sale in Australia
The Therapeutic Goods Administration (TGA) have cleared ResistancePlus® MG FleXible for the Cepheid GeneXpert® System, and it is now available...
6 September 2019
SpeeDx Receives CE-IVD Clearance for ResistancePlus® MG FleXible
ResistancePlus® MG FleXible for the Cepheid GeneXpert® System is now CE-IVD and available for sale in Europe. The test detects...
21 August 2019
Grant Awarded to University Collaboration with SpeeDx
The Australian Research Council (ARC) awarded almost $5 million to a collaboration with SpeeDx and over 20 other organisations, for...
8 August 2019
SpeeDx collaborate on test for premature birth risk
Researchers at The University of Western Australia and King Edward Memorial Hospital have teamed up with SpeeDx to commercialise a...